Skip to main content

Health

NIAMS Skin Biology and Diseases Resource-based Centers (P30)

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for skin biology and diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on skin biology and diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.

Application Due : Jun 11, 2018

Limited Competition for the Continuation of the Clinical Centers for The Environmental Determinants of Diabetes in the Young (TEDDY) Study (U01 Clinical Trial Not Allowed )

This Limited Competition Funding Opportunity Announcement (FOA) invites applications from the Program Directors/Principal Investigators of the six current Clinical Centers (CCs) for The Environmental Determinants of Diabetes in the Young (TEDDY) study, an ongoing epidemiological study of Type 1 Diabetes (T1D) etiology. The TEDDY study involves the rigorous investigation of TEDDY subjects, collecting data and samples, for the identification of infectious agents, dietary factors, or other environmental factors associated with onset of T1D and/or T1D associated autoimmune markers. The six current CCs have been involved in study design and data and biosample acquisition since the inception of the TEDDY consortium. The CCs have recruited participants and followed the subjects over the past 15 years.

Application Due : Apr 10, 2018

Time-Sensitive Research on Health Risk and Resilience after Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands (R21 Clinical Trial Not Allowed)

The purpose of this initiative is to support time-sensitive research on risk and resilience factors related to short- and long-term health outcomes following Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands. In order for research projects to address risk and resilience in the immediate aftermath and/or recovery period after the recent hurricanes, this initiative will use a shortened submission timeline with expedited peer review, council concurrence and award issuance. The entire cycle, from submission to award, is expected to be within 3-4 months.

Application Due : Apr 16, 2018

Substance Abuse Treatment for Children and Adolescents

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Center for Substance Abuse Treatment (CSAT) is accepting applications for fiscal year (FY) 2018 Enhancement and Expansion of Treatment and Recovery Services for Adolescents, Transitional Aged Youth, and their Families grant program (Short Title: Youth and Family TREE). The purpose of this program is to enhance and expand comprehensive treatment, early intervention, and recovery support services for adolescents (ages 12-18), transitional aged youth (ages 16-25), and their families/primary caregivers with substance use disorders (SUD) and/or co-occurring substance use and mental disorders.

Application Due : Apr 10, 2018

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

Application Due : Jan 07, 2021

Notice of Intent to Publish a Funding Opportunity Announcement for A Practice-Based Research Network to Transform Mental Health Care: Science, Service Delivery & Sustainability (U19 Clinical Trial Required)

The NIMH intends to publish a Funding Opportunity Announcement (FOA) Cooperative Agreement (U19) to solicit applications for a practice-based research network to transform mental health care.   The planned FOA will support a practice-based research network in the United States to transform the development, delivery, and sustainability of evidence-based mental health practices and services. Through a research consortium embedded within large and integrated healthcare delivery systems, this Network would result in a continuously learning healthcare system as defined by the Institute of Medicine, to create “a continuous cycle or feedback loop in which scientific evidence informs clinical practice while data gathered from clinical practice and administrative sources inform scientific investigation.

Application Due : June 01, 2018

Training Modules to Enhance the Rigor and Reproducibility of Biomedical Research (R25 Clinical Trial Not Allowed)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs and foster a better understanding of biomedical, behavioral and clinical research and its implications.

Application Due : June 29, 2018

Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed)

The Shared Instrumentation for Animal Research (SIFAR) Grant Program encourages applications from groups of NIH-funded investigators to purchase or upgrade scientific instruments necessary to carry out animal experiments in all areas of biomedical research supported by the NIH. Applicants may request clusters of commercially available instruments configured as specialized integrated systems or as series of instruments to support a thematic well-defined area of research using animals or related materials. Priority will be given to uniquely configured systems to support innovative and potentially transformative investigations. This FOA supports requests for state-of-the art commercially available technologies needed for NIH-funded research using any vertebrate and invertebrate animal species. This funding opportunity announcement (FOA) does not support requests for single instruments. At least one item of the requested instrumentation must cost at least $50,000, after all applicable discounts. No instrument in a cluster can cost less than $20,000, after all applicable discounts. There is no maximum price requirement; however, the maximum award is $750,000.

Application Due : May 31, 2018

Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)

The Shared Instrument Grant (SIG) Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems. The minimum award is $50,000. There is no maximum price requirement; however, the maximum award is $600,000. Types of instruments supported include, but are not limited to: X-ray diffractometers, mass and nuclear magnetic resonance (NMR) spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, cell sorters, and biomedical imagers.

Application Due : May 31, 2018

High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)

The High-End Instrumentation (HEI) Grant Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $600,001. The maximum award is $2,000,000. Types of instruments supported include, but are not limited to: X-ray diffraction systems, nuclear magnetic resonance (NMR) and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-sorters, and biomedical imagers.

Application Due : May 31, 2018

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants (activity codes listed above) that funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project.

Application Due : Sep 07, 2021

Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Gene Editing (U01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications that propose to develop and validate cell- and tissue-based platforms for assessing potential adverse biological consequences of somatic cell genome editing.

Application Due : April 03, 2018

NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24)

In the context of this program, an expert assembles a multi-disciplinary research team that uses an integrative approach to develop rapid and efficient translation of innovative laboratory research findings into therapies, devices or other resources for use by clinicians to treat visual system diseases or disorders. It involves collaborative teams of scientists and clinicians with expertise in multiple disciplines, operating according to a clear leadership plan. Such a collaborative approach is particularly appropriate for research focused on pathways that will likely be targeted by biological intervention, such as gene therapy, cell-based therapy, pharmacological approaches, and the development and use of medical devices. 

Application Due : March 27, 2019

Obesity Policy Evaluation Research (R01)

This Funding Opportunity Announcement (FOA) encourages applications that propose to evaluate policies or large scale programs that are expected to influence obesity related behaviors (e.g., dietary intake, physical activity, or sedentary behavior) and/or weight outcomes have the potential to prevent or reduce rates of obesity. 

Application Due : June 5, 2018

Health-professional Education Partnership Initiative (HEPI) (R25 Clinical Trial Not Allowed)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this Fogarty International Center R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs by enhancing health workforce capacity in high HIV-burden, low-income countriesin sub-Saharan Africa; enhance the diversity of the biomedical, behavioral and clinical research workforce by encouraging interprofessional education initiatives to enhance team health care delivery; help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences in low-income countries to enhance capacity of US research projects; foster a better understanding of biomedical, behavioral and clinical research and its implications to improve capacity to develop, implement and evaluate evidence-based health services.

Application Due : Mar 28, 2018

Tissue Mapping Centers for the Human BioMolecular Atlas Program (U54 Clinical Trials Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to establish state-of-the-art Tissue Mapping Centers (TMCs) that will generate high-resolution, multi-parameter maps of non-diseased human organs and systems. Centers will be expected to integrate and optimize all parts of the data generation pipeline, from tissue collection and preservation through to data integration, analysis and interpretation. Centers will also be expected to work closely with the other funded projects as part of the Human BioMolecular Atlas Program to catalyze development of a framework for mapping the human body with micron resolution.

Application Due : Mar 02, 2018

Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trials Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit transformative technologies that will significantly expand throughput, multiplexing and discrimination of biomolecules in human tissues for comprehensive mapping of individual cells and their context in human tissues. This FOA supports the accelerated proof-of-principle demonstration and validation of promising tools, techniques and systems that can be integrated, scaled and applied to multiple human tissues. The initial two-year UH2 phase will support accelerated development and demonstration of feasibility of these emerging, high impact technologies.

Application Due : Mar 02, 2018

Community Partnerships to Advance Research (CPAR) (R01 Clinical Trial Optional)

This funding opportunity announcement (FOA) encourages researchers to partner with community groups, using Community Engaged Research (CEnR) methodologies that will enhance relationships and lead to better intervention development and positive health outcomes.

Application Due : Feb 05, 2018  

National Cooperative Drug/Device Discovery/Development Groups (U01 Clinical Trial Optional)

The purpose of this initiative is to: accelerate innovative drug and device discovery; develop pharmacologic and neuromodulatory tools for basic and clinical research on mental health, substance use disorders (SUDs) or alcohol addiction; develop and validate tools (pharmacologic or neurostimulation) in support of experimental therapeutic studies of innovative new candidates for mental disorders; and support early stage human studies to rapidly assess the safety, tolerability, and pharmacodynamics of promising drug candidates/devices and new indications for novel Investigational New Drug (IND)-ready agents or Pre-Market Approval (PMA)-ready devices for the treatment of mental disorders, SUDs or alcohol addiction. 

Letter of Intent Due : January 23, 2018

Application Due : February 23, 2018

Collegiate Behavioral Health Prevention, Identification, and Intervention Grant Program

The purpose of this program is to (1) enhance services for all students at risk for suicide, depression, serious mental illness, and substance use disorders that can lead to school failure; (2) prevent mental and substance use disorders; (3) promote help-seeking behavior and reduce stigma; and (4) improve the identification and treatment of at-risk students so that students can successfully complete their studies. The goal is to assist campuses in developing a comprehensive, collaborative, and well-coordinated approach to support prevention efforts and early identification and intervention activities with students at risk for suicide, serious mental illness, and/or substance related overdose or injury.

Reducing Disparities in Vaccination Coverage by Poverty Status Among Young Children: An Assessment of Parental Experience, Barriers, and Challenges with Accessing Quality Vaccination Services

The purpose of this Notice of Funding Opportunity (NOFO) is to gain a better understanding from the parents/guardians of young children about the factors contributing to vaccination coverage disparities observed between young children living below the poverty level and those living at or above the poverty level. These factors may include challenges accessing vaccination services, receiving lower quality vaccination services, Medicaid policy-related barriers, knowledge/attitudes/beliefs toward vaccination, and competing priorities.

Application Due: Jan 18, 2018

Field Initiated Projects Program: Minority-Serving Institution (MSI) -Research

The purpose of the Field Initiated (FI) Projects program is to develop methods, procedures, and rehabilitation technology that maximize the full inclusion and integration into society, employment, independent living, family support, and economic and social self-sufficiency of individuals with disabilities, especially individuals with the most severe disabilities. Another purpose of the FI Projects program is to improve the effectiveness of services authorized under the Rehabilitation Act of 1973, as amended. The purpose of this MS-FI competition is to improve the capacity of minority entities to engage in disability and rehabilitation research and development activities.

Application Due: Feb 15, 2018

Field Initiated Projects Program: Minority-Serving Institution (MSI) - Development

The purpose of the Field Initiated (FI) Projects program is to develop methods, procedures, and rehabilitation technology that maximize the full inclusion and integration into society, employment, independent living, family support, and economic and social self-sufficiency of individuals with disabilities, especially individuals with the most severe disabilities. Another purpose of the FI Projects program is to improve the effectiveness of services authorized under the Rehabilitation Act of 1973, as amended. The purpose of this MSI-FI competition is to improve the capacity of minority entities to engage in disability and rehabilitation research and development activities.

Application Due: Feb 15, 2018

National Cancer Institute Youth Enjoy Science Research Education Program (R25)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Cancer Institute (NCI) R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce.

LOI Due: Dec 25, 2017

Application Due: Jan 25, 2018

Utilizing Health Information Technology to Scale and Spread Successful Practice Models Using Patient-reported Outcomes (R18)

This Funding Opportunity Announcement (FOA) invites R18 grant applications for research that demonstrates how health information technology (IT) can improve patient-centered health outcomes and quality of care in primary care and other ambulatory settings through the scale and spread of successful, health IT-enabled practice models that use patient-reported outcome (PRO) measures to achieve these objectives.

Application Due: Jan 25, 2018

Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 - No Independent Clinical Trials)

This Funding Opportunity Announcement (FOA) encourages applications for short-term mentored career development (K18) awards that improve synergies among researchers in basic and applied behavioral-social sciences, human subjects and model animals settings; and biomedical and behavioral-social sciences.

Application Due: Feb 12, 2018

NLM Grants for Scholarly Works in Biomedicine and Health (G13)

NLM Grants for Scholarly Works in Biomedicine and Health are awarded for the preparation of book-length manuscripts and other works of academic and/or public health policy value to U.S. health professionals, public health officials, biomedical researchers and historians of the health sciences.

Application Due: Feb 23, 2018

Animal and Biological Material Resource Centers (P40)

This FOA encourages grant applications for national Animal Model, and Biological Material Resource Centers. These Centers provide support for special colonies of laboratory animals, as well as other resources such as informatics tools, reagents, cultures (cells, tissues, and organs) and genetic stocks that serve the biomedical research community in a variety of research areas on a local, regional, national and international basis. Support for Animal and Biological Material Resource Centers is limited to those that span the interests of two or more categorical NIH Institutes/Centers/Offices (ICOs). This funding opportunity is designed to both support continuation of existing resources, and to develop new ones when appropriate. Prior to preparing an application, all applicants are strongly encouraged to consult with Scientific/Research staff to be advised on appropriateness of the intended resource plans for this program, competitiveness of a potential application and ORIP's program priorities.

Application Due: Jan 25, 2018

NIBIB Biomedical Technology Resource Centers (P41)

This Funding Opportunity Announcement (FOA) encourages grant applications for Biomedical Technology Resource Centers (BTRCs). BTRCs are national resource centers for conducting research and development on new technologies that are driven by the needs of basic, translational, and/or clinical researchers. BTRCs also make their technologies available to other investigators, train members of the research community in the use of the technologies, and disseminate the technologies broadly.

Application Due : Jan 25, 2018

Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities.

Application Due : Feb 05, 2018

Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01)

This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discover of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur.

Application Due : Jan 16, 2018

BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01) (Clinical Trials Not Allowed)

This funding opportunity announcement (FOA), in support of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, aims to support full development of entirely new or next generation noninvasive human brain imaging tools and methods that will lead to transformative advances in our understanding of the human brain. The FOA seeks innovative applications that are ready for full-scale development of breakthrough technologies with the intention of delivering working tools within the timeframe of the BRAIN Initiative (BRAIN 2025: A Scientific Vision, http://braininitiative.nih.gov/). This FOA represents the second stage of the tool/technology development effort that started with RFA-MH-14-217 and RFA-MH-15-200

Application Due : Dec 11, 2018

Notice of Intent to Publish a Funding Opportunity Announcement for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)

​The National Institute of Neurological Disorders and Stroke (NINDS), intends to re-issue a Program Announcement with Special Review Considerations (PAR) to solicit applications for "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)". The goal of this initiative is to provide support for translational research to develop therapeutics for reducing mortality and morbidity caused by acute exposures to chemical threat agents. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. The scope of the research includes target and candidate identification and characterization, through candidate optimization and demonstration of in vivo efficacy consistent with the product's intended use in humans. 

Application Due : Sep 01, 2018

Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability (U01)

This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer Moonshot InitiativeSM that is intended to accelerate cancer research. The purpose of this FOA is to promote research on developing the descriptive, inferential, and graphical statistical methods for data generated in clinical trials including Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) items. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Accelerate research that can identify approaches to monitor and manage patient-reported symptoms.

Application Due : Jan 17, 2018

Notice of Intent to Publish a Funding Opportunity Announcement for ‘Programs to Increase Diversity among Individuals Engaged in Health Related Research’ (PRIDE) Coordinating Center (U24)

 The National Heart, Lung, and Blood Institute intends to publish a Funding Opportunity Announcement (FOA) to solicit applications for a Coordinating Center (CC) to support the Programs to Increase Diversity among Individuals Engaged in Health Related Research (PRIDE). The PRIDE CC will provide programmatic support to the PRIDE Summer Institutes (R25) whose goal is toenhance the diversity of the biomedical, behavioral and clinical research workforcethrough provision of research education and mentoring programs for junior faculty from under-represented backgrounds. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. 

Application Due : Mar 01, 2018

Agency for Healthcare Research and Quality and Patient-Centered Outcomes Research Institute Learning Health Systems Mentored Career Development Program (K12)

The Agency for Healthcare Research and Quality (AHRQ), in partnership with the Patient-Centered Outcomes Research Institute (PCORI), invites applications for funding to support institutional career development awards designed to train clinician and research scientists to conduct PCOR research within learning health systems (LHS) focused on generation, adoption, and application of evidence in order to improve the quality and safety of care.

Deadline: Jan 29,2018

 Intensive Longitudinal Analysis of Health Behaviors: Leveraging New Technologies to Understand Health Behaviors (U24)

This Funding Opportunity Announcement (FOA) invites applications to establish a Research Coordinating Center (RCC) to facilitate and support the Intensive Longitudinal Health Behaviors Initiative. The goal of this initiative is to support collaborative research projects studying factors that influence key health behaviors at the individual level, using intensive longitudinal data collection and analytic methods, as well as to further advance research through the broad dissemination of data with the research community, as appropriate. The network will also assess how study results can be leveraged to introduce innovations into longstanding behavioral theories to advance the field of theory-driven behavior change interventions.
Letter of Intent: August 25, 2017
Full Application: January 7, 2018

 Department of Defense

DoD Accelerating Innovation in Military Medicine Research Award

The Accelerating Innovation in Military Medicine (AIMM)Research Award is intended to support highly creative and conceptually innovative high-risk research with the potential to accelerate critical discoveries or major advancements that will significantly impact military health and medicine. AIMM initiative funding supports novel research concepts and other efforts that initiate or enhance potential game-changers that may not be supported by other funding mechanisms or core programs. Applications using synthetic or systems biology-based approaches are highly encouraged.

Pre Application: January 26, 2018

Full Application: February 9, 2018

White Paper: This BAA is open and effective through 1 March 2021 at 5:00 pm Local Time, WrightPatterson Air Force Base. White papers may be submitted at any time during this period.

Proposal: To be provided in response to the Requests for Proposals sent to offerors that submit White Papers considered to meet the needs of the Air Force.

The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer. Although not required, investigators are encouraged to address one of the FY17 Areas of Encouragement in their applications.

Full Application: TBD

Breast Cancer Research Program Anticipated Funding Opportunities for Fiscal Year 2017
Due to the current Continuing Resolution, the Fiscal Year 2017 (FY17) Defense Appropriations bill has not been passed. Although funds have not been appropriated for the Department of Defense Breast Cancer Research Program (BCRP), the BCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY17 funding opportunities.
Full Application: TBD

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) Research and Development Directorate (J9) manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
Pre-Application: varies
Full Application:varies

Cancer Prevention and Research Institute of Texas

Evidence Based Cancer Prevention Services

The ultimate goals of the CPRIT Prevention Program are to reduce overall cancer incidence and mortality and to improve the lives of individuals who have survived or are living with cancer. The ability to reduce cancer death rates depends in part on the application of currently available evidence-based technologies and strategies. CPRIT fosters the primary, secondary, and tertiary prevention of cancer in Texas by providing financial support for a wide variety of evidencebased risk reduction, early detection, and survivorship interventions.

Application Due: February 21,2018

Tobacco Control and Lung Cancer Screening

The Tobacco Control and Lung Cancer Screening (TCL) award mechanism seeks to fund programs on tobacco prevention and cessation, as well as screening for early detection of lung cancer. Through release of this RFA, CPRIT’s goal is to stimulate more programs across the state, thereby providing greater access for underserved populations and reducing the incidence and mortality rates of tobacco-related cancers. This RFA seeks to promote and deliver evidence-based programming designed to significantly increase tobacco cessation among adults and/or prevent tobacco use by youth. In addition to evidence-based interventions for tobacco prevention and cessation, screening to detect cancer early, before it has spread, can reduce lung cancer mortality.

Application Due: February 21,2018

Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations

The ability to reduce cancer death rates depends in part on the application of currently available evidence-based technologies and strategies. CPRIT fosters the prevention of cancer in Texas by providing financial support for a wide variety of evidence-based prevention interventions. This award mechanism seeks to support the coordination and expansion of evidence-based services to prevent cancer in underserved populations who do not have adequate access to cancer prevention interventions and health care, bringing together networks of public health and community partners to carry out programs tailored for their communities. Projects should identify cancers that cause the most burden in the community and use evidence-based models to prevent and control these cancers.

Application Due: February 21,2018

This Multi-Investigator Research Award (MIRA) mechanism is intended to support highly integrated programs of collaborative and cross-disciplinary research among multiple Texas investigators. Applications responding to this RFA that address one of the program priorities for academic research adopted by CPRIT’s Oversight Committee are particularly encouraged. MIRAs are expected to promote a cooperative environment that fosters intensive interaction among members in all aspects of the research program. This approach is expected to transform the research process through the integration of basic and/or clinical disciplines, leading to the aggressive translation of scientific discoveries into tools and applications that have the potential to make a significant impact on cancer incidence, detection, treatment, and/or survivorship.
Application Due : January 31,2018.

Core Facility Support Awards (CFSA)

Supports the development or improvement of core facilities that will provide valuable services to support and enhance scientifically meritorious cancer research projects. CPRIT is particularly interested in supporting core facilities that provide enabling services to cancer investigators from multiple Texas institutions. Applications responding to this RFA that address one of the program priorities for academic research adopted by CPRIT’s Oversight Committee are particularly encouraged. 

Application Due : Aug 31, 2018, Internal deadline: Oct 6,2017

Limited: 1 Application per institution.

High-Impact/High-Risk Research Awards (HIHR)

 CPRIT High-Impact/High-Risk (HIHR) Research Awards seek to Provide short-term funding to explore the feasibility of high-risk projects that, if successful, would contribute major new insights into the etiology, diagnosis, treatment, or prevention of cancers. Applications responding to this RFA that address one of the program priorities for academic research adopted by CPRIT’s Oversight Committee are particularly encouraged.

Application Due : Jan 31, 2018, Internal deadline: Oct 6,2017

 Limited: A PI may submit only 1 new or resubmission application under this RFA during this funding cycle.

American Association for Cancer Research 

NASA

2017 NASA HERO NRA

This National Aeronautics and Space Administration (NASA) Research Announcement (NRA), entitled Human Exploration Research Opportunities (HERO)–2017, solicits research in support of NASA’s Human Research Program (HRP). The HRP contains six Elements: Space Radiation, Human Health and Countermeasures, Exploration Medical Capability, Behavioral Health and Performance, Space Human Factors and Habitability, and International Space Station Medical Project. Fourteen disciplines or areas support the Program: Behavioral Health and Performance, Bone, Cardiovascular, Extravehicular Activity, Immunology, Medical Capabilities, Muscle, Nutrition, Pharmacology, Radiation, Sensorimotor, Advanced Food Technology, Advanced Environmental Health, and Space Human Factors Engineering. Awards generally range from under $100K per year for focused, limited efforts (e.g., data analysis) to $1M per year for extensive activities (e.g., development of scientific hardware). The funds available for awards in each program element offered in this solicitation range from less than one to several million dollars, which allows NASA to select a few to numerous proposals depending on the program objectives and the submission of proposals of merit. This solicitation may result in grant, cooperative agreement, and contract awards. 

Deadlines vary. See http://nspires.nasaprs.com/ for more information.

Patient-Centered Outcomes Research Institute (PCORI)

Improving Methods for Conducting Patient-Centered Outcomes Research (PCOR)

In this PCORI Funding announcement (PFA), we will fund projects to adress gaps in methodological research relevant to conducting patient-centered outcomes research (PCOR)/comparative effectiveness research (CER). The improvement of existing methods will benefit all stakeholders, including researchers planning investigations; policy makers weighing the value of healthcare interventions; and patients, clinicians, and caregivers facing healthcare decisions.

LOI Due: 10/31/2017

Deadline: 2/6/2018

PCORI Funding Announcement: Improving Healthcare Systems

The Improving Healthcare Systems (IHS) Program within PCORI invites applications for research that studies the comparative effectiveness of alternative features of healthcare systems (e.g., innovative technologies,incentive structures, or healthcare service delivery designs) that are intended to optimize the quality, outcomes, and efficiency of patient care and that have the greatest potential for sustained impact and replication within and across healthcare systems. Healthcare systems encompass multiple levels (e.g., individual patients, family and social supports, providers and care teams, organizations or practice settings, local community resources, and the state- and national-level policy environments) and include entities organized to deliver, arrange, purchase, or coordinate health services.

LOI: 10/31/2017

Deadline: 2/6/2018

PCORI Funding Announcement: Addressing Disparities

PCORI invites applications for clinical comparative effectiveness research (CER) designed to evaluate and compare interventions intended to reduce or eliminate disparities in health and health care. Patients, caregivers, and clinicians often lack the appropriate evidence required to make the best choices regarding prevention, screening, diagnosis, monitoring, or treatment. Applications to the Addressing Disparities Program should focus on overcoming barriers that may disproportionately affect health outcomes or focus on identifying best practices for reducing disparities in target populations (racial and ethnic minority groups; low-income groups; residents of rural areas; individuals with special healthcare needs, including individuals with disabilities; patients with low health literacy/numeracy and/or limited English proficiency; and lesbian, gay, bisexual, and transgender [LGBT] persons). 

LOI: 10/31/2017

Deadline: 2/6/2018